Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.6M Buy
6,246
+1,606
+35% +$571K 0.01% 895
2026
Q1
$1.34M Sell
4,640
-67
-1% -$18.6K 0.01% 1136
2025
Q4
$1.19M Buy
4,707
+1,556
+49% +$419K 0.01% 1132
2025
Q3
$1.02M Buy
3,151
+11
+0.4% +$3.44K 0.01% 1078
2025
Q2
$924K Buy
3,140
+373
+13% +$103K 0.01% 1019
2025
Q1
$723K Sell
2,767
-319
-10% -$89.2K 0.01% 964
2024
Q4
$785K Sell
3,086
-42
-1% -$10K 0.01% 874
2024
Q3
$673K Buy
+3,128
New +$606K 0.01% 731

Other funds holding FFIV

&Partners's FFIV Position: Q2 2026 in Review

&Partners increased its F5 (FFIV) stake by 35% in Q2 2026, buying an estimated $571K and bringing the position to 6,246 shares worth $2.6M. The position accounts for 0.01% of the portfolio, ranked #895.

&Partners first reported a position in FFIV in Q3 2024 and has held it in 8 quarters since. 831 funds tracked by Wall St. Rank hold FFIV as of Q2 2026.

  • &Partners held 6,246 shares of F5 worth $2.6M as of Q2 2026.
  • &Partners bought 1,606 F5 shares in Q2 2026, an estimated $571K.
  • F5 made up 0.01% of &Partners's portfolio in Q2 2026, its #895 holding.
  • &Partners first reported a position in F5 in Q3 2024 and has held it in 8 quarters since.
  • 831 funds tracked by Wall St. Rank held F5 as of Q2 2026.

Based on &Partners's 13F filing for Q2 2026, filed 14 Aug 2026.